Alterity Therapeutics

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell ATHE and other ETFs, options, and stocks.

About ATHE

Alterity Therapeutics Ltd. is a clinical stage biotechnology company. It engages in the business of research and development of therapeutic drugs designed to treat the underlying cause of degeneration of the brain focusing on Alzheimer's, Huntington, Parkinson’s, and other neurological disorders.

CEO

David A. Stamler

CEODavid A. Stamler

Employees

Employees11

Headquarters

Melbourne, Victoria (VIC)

HeadquartersMelbourne, Victoria (VIC)

Founded

1997

Founded1997

Employees

Employees11

ATHE Key Statistics

Market cap

19.71M

Market cap19.71M

Price-Earnings ratio

-1.04

Price-Earnings ratio-1.04

Dividend yield

—

Dividend yield—

Average volume

71.26K

Average volume71.26K

High today

$2.15

High today$2.15

Low today

$2.05

Low today$2.05

Open price

$2.08

Open price$2.08

Volume

14.42K

Volume14.42K

52 Week high

$5.41

52 Week high$5.41

52 Week low

$1.55

52 Week low$1.55

ATHE News

TipRanks 2d

BNYMC Ups Stake in Alterity Therapeutics

Alterity Therapeutics Ltd. (AU:ATH) has released an update. Alterity Therapeutics Limited reports a change in substantial holding by The Bank of New York Mello...

TipRanks 5d

Alterity Therapeutics Adds New Shares Post-Options

Alterity Therapeutics (ATHE) has released an update. Alterity Therapeutics Limited has announced the issuance of 7,097,419 new ordinary fully paid shares as a...